Answers are grounded in this paper and cite their sources.
Deoxycholic acid (ATX-101) is a drug administered by subcutaneous injection for local fat reduction. However, ATX-101 treatment has been reported to cause marginal mandibular nerve injury with noticeable functional deficits when targeting submental fat. As a cytolytic agent with some selectivity for adipocytes, ATX-101 may damage the lipid-rich myelin surrounding peripheral nerves.
No takes yet. Share an insight, caveat, or question.
Chi et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: